If you or a loved one takes ramipril to manage high blood pressure, heart failure, or to reduce the risk of heart attack and stroke, please read this important update carefully.
The U.S. Food and Drug Administration (FDA) and Lupin Pharmaceuticals have announced a voluntary nationwide recall of more than 600,000 bottles of ramipril capsules due to concerns that the active pharmaceutical ingredient (API) may have come from an unapproved and uninspected manufacturing facility in India.
Ramipril is a widely prescribed ACE inhibitor used by millions of Americans every year to help control hypertension and protect against serious cardiovascular and kidney complications. This recall affects specific lots, but the vast majority of ramipril products on the market remain unaffected.
Products affected include:
- Ramipril capsules in strengths of 2.5 mg, 5 mg, and 10 mg
- Bottle sizes: 90-count, 100-count, and 500-count
- Expiration dates extending through July 2026
The recall is being conducted out of an abundance of caution. To date, no illnesses or adverse events have been reported in connection with the affected lots.
Important guidance for patients – do NOT stop your medication without medical advice
Suddenly stopping ramipril can cause a dangerous rebound increase in blood pressure. If your bottle is part of the recall:
- Check the label for the lot number, expiration date, and manufacturer (Lupin Pharmaceuticals).
- If it matches the recalled lots, contact your pharmacist or healthcare provider immediately.
- Most pharmacies can provide replacement medication at no additional cost.
- Your doctor may prescribe an equivalent ACE inhibitor such as lisinopril, enalapril, or another suitable alternative to maintain continuous blood pressure control.
Anyone experiencing unexpected symptoms (such as dizziness, unusual fatigue, swelling, or chest pain) should seek medical attention promptly and report the issue to their healthcare provider and to the FDA’s MedWatch program.
This recall serves as a reminder of the importance of rigorous quality oversight throughout the global pharmaceutical supply chain. Regulatory agencies and manufacturers continue to work together to ensure that medications remain safe, effective, and of high quality.
For the latest list of affected lot numbers and full details, visit the official FDA recall page or Lupin Pharmaceuticals’ website.
If you have questions about your specific medication, speak with your pharmacist or prescribing physician today. Your health and safety remain the top priority.
(Information based on official FDA and manufacturer announcements as of March 2026. This is not medical advice—always consult a healthcare professional for personalized guidance.)
